CD47 and pulmonary fibrosis: Meanwhile, the preclinical study demonstrated that the blockade of IL-6, CD47, and PD-L1 together could ameliorate pulmonary fibrosis by increasing phagocytosis of profibrotic fibroblasts and by eliminating suppressive effects on adaptive immunity (20).